National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically—third edition; approved standard . Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993;; NCCLS document no. M7-A3 (vol 13, no. 25).
Gorwitz RJ, Nakashima AK, Moran JS, Knapp JS, The Gonococcal Isolate Surveillance Project Study Group. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae—United States, 1988-1991. MMWR 1993;;42(no.
(SS-3)
):29-39.
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests—5th edition; approved standard . Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993;; NCCLS document no M2-A5 (vol 13, no. 24).
Clendennen TE, Echeverria P, Saengeur PS, Kees ES, Boslego JW, Wignall FS. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother 1992;;36:1682-7.
Tapsall JW, Lovett R, Munro R. Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhea. Med J Aust 1992;;156:143.
Barry AL, Jones RN. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations. Antimicrob Agents Chemother 1984;;25:775-7.
Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT. Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother 1987;;31:535-8.
Bogaerts J, Tello WM, Akingeneye J, Mudantabana V, van Dyck E. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourin Med 1993;;69:196-200.
Tartaglione TA, Russo ME. Pharmacology of drugs used in venereology. In: Holmes KK, Merdh P-A, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases . 2nd ed. New York: McGraw-Hill Information Services Company, 1990;:993-1019.
CDC. 1989 Sexually transmitted diseases treatment guidelines. MMWR 1989;;38 (no.
(SS-8)
).